Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2022-02-09 10:24 am Purchase | 13G | RIGEL PHARMACEUTICALS INC RIGL | FMR LLC | 24,571,593 14.368% | 3,658,490 (+17.49%) | View |
| 2022-02-01 5:08 pm Sale | 13G | RIGEL PHARMACEUTICALS INC RIGL | BlackRock Inc. BLK | 16,551,984 9.7% | -941,436 (-5.38%) | View |
| 2021-09-10 08:54 am Sale | 13G | RIGEL PHARMACEUTICALS INC RIGL | WELLINGTON MANAGEMENT GROUP LLP | 1,406,200 0.82% | -9,792,371 (-87.44%) | View |
| 2021-02-16 4:39 pm Sale | 13G | RIGEL PHARMACEUTICALS INC RIGL | INTEGRATED CORE STRATEGIES (US) LLC | 1,028,480 0.6% | -7,496,938 (-87.94%) | View |
| 2021-02-11 07:18 am Purchase | 13G | RIGEL PHARMACEUTICALS INC RIGL | STATE STREET CORP STT | 9,362,504 5.54% | 9,362,504 (New Position) | View |
| 2021-02-10 11:51 am Purchase | 13G | RIGEL PHARMACEUTICALS INC RIGL | VANGUARD GROUP INC | 9,145,599 5.41% | 310,362 (+3.51%) | View |
| 2021-02-08 10:31 am Sale | 13G | RIGEL PHARMACEUTICALS INC RIGL | FMR LLC | 20,913,103 12.375% | -1,927,961 (-8.44%) | View |
| 2021-02-04 11:42 am Sale | 13G | RIGEL PHARMACEUTICALS INC RIGL | WELLINGTON MANAGEMENT GROUP LLP | 11,198,571 6.63% | -5,608,690 (-33.37%) | View |
| 2021-01-26 6:52 pm Purchase | 13G | RIGEL PHARMACEUTICALS INC RIGL | BlackRock Inc. BLK | 17,493,420 10.4% | 274,316 (+1.59%) | View |
| 2020-07-10 10:39 am Purchase | 13G | RIGEL PHARMACEUTICALS INC RIGL | BlackRock Inc. BLK | 17,219,104 10.2% | 2,510,819 (+17.07%) | View |
| 2020-02-14 4:21 pm Sale | 13G | RIGEL PHARMACEUTICALS INC RIGL | INTEGRATED CORE STRATEGIES (US) LLC | 8,525,418 5.1% | -231,398 (-2.64%) | View |
| 2020-02-11 4:44 pm Purchase | 13G | RIGEL PHARMACEUTICALS INC RIGL | VANGUARD GROUP INC | 8,835,237 5.27% | 5,063,295 (+134.24%) | View |
| 2020-02-07 11:28 am Sale | 13G | RIGEL PHARMACEUTICALS INC RIGL | FMR LLC | 22,841,064 13.627% | -2,154,944 (-8.62%) | View |
| 2020-02-06 09:10 am Purchase | 13G | RIGEL PHARMACEUTICALS INC RIGL | BlackRock Inc. BLK | 14,708,285 8.8% | 983,825 (+7.17%) | View |
| 2020-01-27 3:56 pm Sale | 13G | RIGEL PHARMACEUTICALS INC RIGL | WELLINGTON MANAGEMENT GROUP LLP | 16,807,261 10.03% | -6,521,175 (-27.95%) | View |
| 2019-11-14 4:47 pm Purchase | 13G | RIGEL PHARMACEUTICALS INC RIGL | INTEGRATED CORE STRATEGIES (US) LLC | 8,756,816 5.2% | 8,756,816 (New Position) | View |